danoprevir placebo

DRUG2 trials

Sponsors

Hoffmann-La Roche, Ascletis Pharmaceuticals Co., Ltd.

Conditions

HCVHealthy Volunteer

Phase 1

A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects

CompletedNCT01398293

Hoffmann-La RocheHealthy Volunteer

Start: 2011-08-31End: 2011-11-30Updated: 2016-11-02

Phase 2

Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.

CompletedNCT03362814

Ascletis Pharmaceuticals Co., Ltd.HCV

Start: 2017-07-01End: 2019-04-24Updated: 2020-07-28

Related Papers

Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China

Journal of Clinical and Translational Hepatology2019-09-2816 citations